Link to this page
COVID-19 Ontology
| Preferred Name | formoterol | |
| Synonyms |
(+-)-2'-hydroxy-5'-((RS)-1-hydroxy-2-(((RS)-p-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide (R*,R*)-(+-)-N-[2-hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl)phenyl]formamide formoterolum N-{2-hydroxy-5-[(1RS)-1-hydroxy-2-{[(2RS)-1-(4-methoxyphenyl)propan-2-yl]amino}ethyl]phenyl}formamide (+-)-formoterol formoterol rac-N-{2-hydroxy-5-[(1R)-1-hydroxy-2-{[(2R)-1-(4-methoxyphenyl)propan-2-yl]amino}ethyl]phenyl}formamide |
|
| Definitions |
A racemate consisting of equal amounts of arformoterol (the active enantiomer) and (S,S)-formoterol (the inactive enantiomer). Its fumaric acid salt is used as a direct-acting sympathomimetic and bronchodilator for the treatment of chronic obstructive pulmonary disease (any progressive respiratory disease that makes it harder to breathe over time, such as chronic bronchitis and emphysema). |
|
| ID |
http://purl.obolibrary.org/obo/CHEBI_5147 |
|
| alternative_term |
rac-N-{2-hydroxy-5-[(1R)-1-hydroxy-2-{[(2R)-1-(4-methoxyphenyl)propan-2-yl]amino}ethyl]phenyl}formamide
|
|
| charge |
0
|
|
| database_cross_reference |
Patent:US3994974 KEGG:C07805 Patent:DE2305092 CAS:73573-87-2 Reaxys:6741801 KEGG:D07990 DrugBank:DB00983 Wikipedia:Formoterol
|
|
| definition |
A racemate consisting of equal amounts of arformoterol (the active enantiomer) and (S,S)-formoterol (the inactive enantiomer). Its fumaric acid salt is used as a direct-acting sympathomimetic and bronchodilator for the treatment of chronic obstructive pulmonary disease (any progressive respiratory disease that makes it harder to breathe over time, such as chronic bronchitis and emphysema).
|
|
| formula |
C19H24N2O4
|
|
| fromPubMed |
true
|
|
| has_obo_namespace |
chebi_ontology
|
|
| has_related_synonym |
(+-)-2'-hydroxy-5'-((RS)-1-hydroxy-2-(((RS)-p-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide (R*,R*)-(+-)-N-[2-hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl)phenyl]formamide formoterolum N-{2-hydroxy-5-[(1RS)-1-hydroxy-2-{[(2RS)-1-(4-methoxyphenyl)propan-2-yl]amino}ethyl]phenyl}formamide (+-)-formoterol formoterol
|
|
| id |
CHEBI:5147
|
|
| imported from | ||
| in_subset | ||
| label |
formoterol
|
|
| mass |
344.40490
|
|
| monoisotopicmass |
344.17361
|
|
| notation |
CHEBI:5147
|
|
| oboInOwl:hasDbXRef | ||
| preferred label |
formoterol
|
|
| prefLabel |
formoterol
|
|
| textual definition |
A racemate consisting of equal amounts of arformoterol (the active enantiomer) and (S,S)-formoterol (the inactive enantiomer). Its fumaric acid salt is used as a direct-acting sympathomimetic and bronchodilator for the treatment of chronic obstructive pulmonary disease (any progressive respiratory disease that makes it harder to breathe over time, such as chronic bronchitis and emphysema).
|
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |